Skip to main content
Livermore
Livermore
ZHEN

Deep Track Capital, LP

SEC CIK
0001856083
Latest filing
Aug 14, 2026

Holdings in Q4 2022

Holdings as of Dec 31, 2022, filed Feb 14, 2023. Long positions only; changes compare share counts with Q3 2022.

Institution overview
Positions
57
−3 vs. Q3 2022
Portfolio value
$2.29B
+$269.9M (+13.3%) vs. Q3 2022
Filed
Feb 14, 2023
SEC
Holdings of Deep Track Capital, LP in Q4 2022
SecurityClassSharesValue% of portfolioShare changeActionHistory
IMVTImmunovant, Inc.COM9,710,000$172.4M7.5%−150,246−1.5%ReducedHistory
ISEEIVERIC bio, Inc.COM7,878,119$168.7M7.4%+878,119+12.5%AddedHistory
JAZZJazz Pharmaceuticals plcSHS USD873,553$139.2M6.1%+12,553+1.5%AddedHistory
TVTXTravere Therapeutics, Inc.COM4,582,000$96.4M4.2%+582,000+14.5%AddedHistory
ASNDAscendis Pharma A/SSPONSORED ADR700,000$85.5M3.7%−100,000−12.5%ReducedHistory
INSMINSMED IncCOM PAR $.014,264,292$85.2M3.7%+4,264,292NewHistory
BCYCBicycle Therapeutics PLCSPONSORED ADS2,819,045$83.4M3.6%−80,955−2.8%ReducedHistory
VRNAVerona Pharma plcSPONSORED ADS3,187,415$83.3M3.6%+358,321+12.7%AddedHistory
BIIBBiogen Inc.COM300,000$83.1M3.6%+300,000NewHistory
SWTXSpringWorks Therapeutics, Inc.COM3,109,886$80.9M3.5%+740,676+31.3%AddedHistory
KDNYChinook Therapeutics, Inc.COM3,000,000$78.6M3.4%00.0%UnchangedHistory
SRPTSarepta Therapeutics, Inc.COM528,244$68.4M3.0%+528,244NewHistory
AGENAgenus IncCOM NEW27,000,000$64.8M2.8%+675,000+2.6%AddedHistory
FDMT4D Molecular Therapeutics, Inc.COM2,656,901$59.0M2.6%−539,741−16.9%ReducedHistory
HZNPHorizon Therapeutics Public Ltd CoSHS500,000$56.9M2.5%−962,800−65.8%ReducedHistory
DICEDICE Therapeutics, Inc.COM1,734,143$54.1M2.4%+734,143+73.4%AddedHistory
VRDNViridian Therapeutics, Inc.COM1,771,154$51.7M2.3%−199,136−10.1%ReducedHistory
ETNB89bio, Inc.COM3,850,000$49.0M2.1%+1,214,000+46.1%AddedHistory
BEAMBeam Therapeutics Inc.COM1,166,473$45.6M2.0%+166,473+16.6%AddedHistory
IONSIonis Pharmaceuticals IncCOM1,205,773$45.5M2.0%+1,205,773NewHistory
ALLKAllakos Inc.COM4,899,179$41.3M1.8%+380,604+8.4%AddedHistory
RPTXRepare Therapeutics Inc.COM2,727,606$40.1M1.7%−400,061−12.8%ReducedHistory
ALBOAlbireo Pharma, Inc.COM1,704,000$36.8M1.6%+593,376+53.4%AddedHistory
PLRXPliant Therapeutics, Inc.COM1,732,946$33.5M1.5%+333,202+23.8%AddedHistory
DYNDyne Therapeutics, Inc.COM2,684,200$31.1M1.4%−500,000−15.7%ReducedHistory
EWTXEdgewise Therapeutics, Inc.COM3,374,394$30.2M1.3%00.0%UnchangedHistory
SLNSilence Therapeutics plcADS1,951,580$29.8M1.3%00.0%UnchangedHistory
AUTLAutolus Therapeutics plcSPON ADS15,000,000$28.5M1.2%+15,000,000NewHistory
ATXSAstria Therapeutics, Inc.COM1,816,531$27.0M1.2%+1,816,531NewHistory
VIGLVigil Neuroscience, Inc.COM2,104,174$26.3M1.1%−259,014−11.0%ReducedHistory
RAPTRAPT Therapeutics, Inc.COM1,304,940$25.8M1.1%+1,304,940NewHistory
ESPREsperion Therapeutics, Inc.COM4,000,000$24.9M1.1%−1,636,587−29.0%ReducedHistory
NRIXNurix Therapeutics, Inc.COM2,266,569$24.9M1.1%+212,948+10.4%AddedHistory
DVAXDynavax Technologies CorpCOM NEW2,327,951$24.8M1.1%+2,327,951NewHistory
NTLAIntellia Therapeutics, Inc.COM700,000$24.4M1.1%+400,000+133.3%AddedHistory
ABOSAcumen Pharmaceuticals, Inc.COM3,952,000$21.3M0.9%+173,182+4.6%AddedHistory
BMRNBiomarin Pharmaceutical IncCOM189,800$19.6M0.9%−549,063−74.3%ReducedHistory
CRNXCrinetics Pharmaceuticals, Inc.COM1,048,829$19.2M0.8%−4,171−0.4%ReducedHistory
GERNGeron CorpCOM7,414,693$17.9M0.8%+7,414,693NewHistory
HRTXHeron Therapeutics, Inc.COM6,496,976$16.2M0.7%−2,051,411−24.0%ReducedHistory
NUVBNuvation Bio Inc.COM CL A8,221,188$15.8M0.7%−1,104,352−11.8%ReducedHistory
SNDXSyndax Pharmaceuticals IncCOM500,000$12.7M0.6%+500,000NewHistory
RLMDRelmada Therapeutics, Inc.COM2,837,818$9.90M0.4%+2,376,957+515.8%AddedHistory
PTGXProtagonist Therapeutics, IncCOM871,493$9.51M0.4%+871,493NewHistory
NKTXNkarta, Inc.COM1,354,200$8.11M0.4%−1,460,644−51.9%ReducedHistory
Avidity Biosciences, Inc.05370A108COM300,000$6.66M0.3%+300,000New–
VKTXViking Therapeutics, Inc.COM610,083$5.73M0.2%+610,083NewHistory
FULCFulcrum Therapeutics, Inc.COM768,607$5.60M0.2%−132,104−14.7%ReducedHistory
GHRSGH Research PLCORDINARY SHARES499,400$4.85M0.2%00.0%UnchangedHistory
JNCEJounce Therapeutics, Inc.COM4,259,653$4.73M0.2%00.0%UnchangedHistory
IPSCCentury Therapeutics, Inc.COM695,845$3.57M0.2%−228,796−24.7%ReducedHistory
INZYInozyme Pharma, Inc.COM3,250,000$3.41M0.1%00.0%UnchangedHistory
ASMBAssembly Biosciences, Inc.COM1,833,437$2.38M0.1%−1,166,563−38.9%ReducedHistory
THRDThird Harmonic Bio, Inc.COM445,572$1.92M0.1%−822,648−64.9%ReducedHistory
AUPHAurinia Pharmaceuticals Inc.COM324,238$1.40M0.1%−5,353,134−94.3%ReducedHistory
DNTHDianthus Therapeutics, Inc.COM3,000,000$1.19M0.1%−2,359,000−44.0%ReducedHistory
HOOKHOOKIPA Pharma Inc.COM1,240,369$1.00M<0.1%−3,795,629−75.4%ReducedHistory

Options (3)

Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.

Option positions of Deep Track Capital, LP in Q4 2022
SecurityClassPutsCalls
HZNPHorizon Therapeutics Public Ltd CoSHS$56.9M–
ASNDAscendis Pharma A/SSPONSORED ADR–$30.4M
RETAReata Pharmaceuticals IncCL A–$478.7K

Sold out since Q3 2022 (16)

Positions held at the end of Q3 2022 that are gone from this filing.

Positions of Deep Track Capital, LP sold out since Q3 2022
SecurityClassShares in Q3 2022Value in Q3 2022% of portfolio in Q3 2022History
NVCRNovoCure LtdORD SHS1,293,761$98.3M4.9%History
KURAKura Oncology, Inc.COM3,186,083$43.5M2.2%History
FATEFate Therapeutics IncCOM1,311,113$29.4M1.5%History
AKROAkero Therapeutics, Inc.COM790,926$26.9M1.3%History
VERVVerve Therapeutics, Inc.COM775,000$26.6M1.3%History
KALVKalVista Pharmaceuticals, Inc.COM1,824,000$26.5M1.3%History
GBTGlobal Blood Therapeutics, Inc.COM326,600$22.2M1.1%History
FMTXForma Therapeutics Holdings, Inc.SHS966,573$19.3M1.0%History
ARDXArdelyx, Inc.COM14,858,000$17.7M0.9%History
TCDATricida, Inc.COM1,177,680$12.3M0.6%History
ACETAdicet Bio, Inc.COM825,508$11.7M0.6%History
KROSKeros Therapeutics, Inc.COM248,500$9.35M0.5%History
ANABAnaptysbio, IncCOM360,000$9.18M0.5%History
SDGRSchrodinger, Inc.COM170,000$4.25M0.2%History
PASGPassage BIO, Inc.COM1,439,062$1.80M0.1%History
GRTSGritstone bio, Inc.COM45,500$117.0K<0.1%History